Dosimetry during adjuvant (131)I therapy in patients with differentiated thyroid cancer-clinical implications

The activity of radioiodine ((131)I) used in adjuvant therapy for thyroid cancer ranges between 30 mCi (1.1 GBq) and 150 mCi (5.5 GBq). Dosimetry based on Marinelli's formula, taking into consideration the absorbed dose in the postoperative tumour bed (D) should systematise the determination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Szumowski, Piotr, Abdelrazek, Saeid, Iwanicka, Dorota, Mojsak, Małgorzata, Sykała, Monika, Żukowski, Łukasz, Siewko, Katarzyna, Adamska, Agnieszka, Maliszewska, Katarzyna, Popławska-Kita, Anna, Szelachowska, Małgorzata, Krętowski, Adam, Myśliwiec, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260769/
https://www.ncbi.nlm.nih.gov/pubmed/34230618
http://dx.doi.org/10.1038/s41598-021-93431-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260769/
https://www.ncbi.nlm.nih.gov/pubmed/34230618
http://dx.doi.org/10.1038/s41598-021-93431-1

Ejemplares similares